NCT03031899

Brief Summary

Abstract Objective: To study the diagnostic efficiency of Rose Bengal with Toluidine blue in detecting the biopsy sites and thus establish an accurate diagnosis in oral premalignant lesions. Materials and method: In our study 27 patients with 41 lesions were included. Since one patient had not quit the habit in the two weeks following initial examination and another lesion disappeared in the waiting period, 2 patients (3 lesions) were not included in the study. Out of 38 lesions diagnosed based on clinical criteria, 32 were leukoplakia, 5 lichen planus and 1 SCC. After initial examination they were subjected to Rose Bengal and Toluidine blue stain. If stained positive they were subjected to biopsy.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2015

Shorter than P25 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2015

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2016

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

December 14, 2016

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 26, 2017

Completed
1.8 years until next milestone

Results Posted

Study results publicly available

November 5, 2018

Completed
Last Updated

November 5, 2018

Status Verified

March 1, 2018

Enrollment Period

1 year

First QC Date

December 14, 2016

Results QC Date

February 2, 2017

Last Update Submit

March 6, 2018

Conditions

Outcome Measures

Primary Outcomes (2)

  • Number and Percentage of Lesions That Were Stained Positive

    outcome measure1

    2 weeks

  • Sensitivity and Specificity (Percentage of True Positives and True Negatives)

    sensitivity: Percentage of lesions stained positive with Toluidine blue stain that were also stained positive with Rose Bengal stain specificity: Percentage of lesions stained negative with Toluidine blue stain that were also stained negative with Rose Bengal stain

    2 weeks

Secondary Outcomes (1)

  • Presence of Dysplasia in Biopsied Lesions That Were Stained by Rose Bengal

    2 weeks

Study Arms (2)

Rose Bengal positive lesion and biopsy

Lesions that were stained positive with rose bengal were biopsied and assessed for dysplasia

Procedure: BiopsyDiagnostic Test: Rose Bengal

Toluidine blue positive lesion and biopsy

Lesions that were stained positive with toluidine blue were biopsied and assessed for dysplasia

Procedure: BiopsyDiagnostic Test: toluidine blue

Interventions

BiopsyPROCEDURE

rose bengal stain and toluidine is applied over a premalignant lesion and positively stained lesions are subjected to biopsy.

Rose Bengal positive lesion and biopsyToluidine blue positive lesion and biopsy
Rose BengalDIAGNOSTIC_TEST

the lesions stained positive were subjected to biopsy

Rose Bengal positive lesion and biopsy
toluidine blueDIAGNOSTIC_TEST

the lesions stained positive were subjected to biopsy

Toluidine blue positive lesion and biopsy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study group consists of 41 oral premalignant lesions in patients visiting the Department of Oral Medicine and Radiology of The Oxford Dental College and Hospital, Bangalore.

You may qualify if:

  • Patients with clinically diagnosed oral premalignant lesions (oral leukoplakia and oral lichen planus).

You may not qualify if:

  • Patients with OSMF
  • bleeding disorders and
  • other systemic diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITH DNA

Biopsy specimen of the lesion was retained.

MeSH Terms

Conditions

Leukoplakia, OralLichen Planus, Oral

Interventions

Biopsy

Condition Hierarchy (Ancestors)

Mouth NeoplasmsHead and Neck NeoplasmsNeoplasms by SiteNeoplasmsLeukoplakiaPrecancerous ConditionsMouth DiseasesStomatognathic DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsLichen PlanusLichenoid EruptionsSkin Diseases, PapulosquamousSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

CytodiagnosisCytological TechniquesClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisSpecimen HandlingDiagnostic Techniques, SurgicalSurgical Procedures, OperativeInvestigative Techniques

Limitations and Caveats

1. small sample size 2. only lesions stained positive were selected for biopsy procedure hence interpretation of the staining was limited to certain lesions only 3. a colorimetric guide was not used measure the intensity of staining

Results Point of Contact

Title
Dr. Anisha Yaji
Organization
The Oxford Dental college

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
doctor

Study Record Dates

First Submitted

December 14, 2016

First Posted

January 26, 2017

Study Start

March 1, 2015

Primary Completion

March 1, 2016

Study Completion

March 1, 2016

Last Updated

November 5, 2018

Results First Posted

November 5, 2018

Record last verified: 2018-03

Data Sharing

IPD Sharing
Will not share